Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $13.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its price target lowered by Lake Street Capital from $25.00 to $13.00 in a report issued on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the stock.

BIOX has been the subject of a number of other reports. Canaccord Genuity Group restated a buy rating and issued a $17.00 target price on shares of Bioceres Crop Solutions in a research note on Friday, July 19th. Roth Mkm began coverage on shares of Bioceres Crop Solutions in a research report on Tuesday, July 2nd. They set a buy rating and a $15.00 target price for the company. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a strong-buy rating in a report on Friday, July 19th. Finally, Roth Capital raised Bioceres Crop Solutions to a strong-buy rating in a research note on Tuesday, July 2nd. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of Buy and an average price target of $13.63.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ:BIOX opened at $8.56 on Wednesday. Bioceres Crop Solutions has a 12 month low of $8.16 and a 12 month high of $14.05. The company has a market cap of $537.57 million, a price-to-earnings ratio of 856.00 and a beta of 0.49. The company has a 50-day moving average price of $10.43 and a 200-day moving average price of $11.41. The company has a current ratio of 1.28, a quick ratio of 0.83 and a debt-to-equity ratio of 0.35.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The firm had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. During the same quarter in the prior year, the company earned ($0.06) EPS. As a group, equities analysts anticipate that Bioceres Crop Solutions will post 0.81 EPS for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Hedge funds have recently bought and sold shares of the stock. Activest Wealth Management bought a new position in shares of Bioceres Crop Solutions in the first quarter worth $30,000. Cape Investment Advisory Inc. acquired a new position in shares of Bioceres Crop Solutions during the fourth quarter worth approximately $33,000. Oppenheimer & Co. Inc. bought a new stake in shares of Bioceres Crop Solutions in the 1st quarter worth about $139,000. Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions during the first quarter worth approximately $212,000. Finally, Ping Capital Management Inc. bought a new stake in Bioceres Crop Solutions in the 2nd quarter valued at $448,000. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.